A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
·
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
OTHER
·

Directory Results for This option will vest in its entirety on May 19, 2020, subject to the reporting person's continued service to Five Prime Therapeutics, Inc to This option, originally representing a right to purchase 60,000 shares, became exercisable as to one-fourth (1/4) of the shares on March 31, 2004, with the remainder becoming exercisable in 36 monthly

This option will vest in its entirety on May 19, 2020, subject to the reporting person's continued service to Five Prime Therapeutics, Inc
This option would
This option, originally representing a right to purchase 60,000 shares, became exercisable as to one-fourth (1/4) of the shares on March 31, 2004, with the remainder becoming exercisable in 36 monthly